Total Funding
71
50
Total FundingPost-IPO Equity raised
Growth Score
-18 pts
Heat Score
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
202964
PainReform Ltd is a phamaceutical company that specializes in the reformulation of current pain medications to benefit the patient better.
- Sigal Aviel: COO
- Ilan Hadar: Chief Executive Officer
About the Company
PainReform is a specialty pharmaceutical company that develops products for the treatment of pain. Focused on reformulations of established pain drugs for the US FDA 505(b)(2) regulatory pathway, PainReform applies unique technologies to enhance efficacy, reduce adverse effects and increase convenience as well as faster return of motor function.
